Granite Harbor Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Sell |
4,748
-241
| -5% | -$18.8K | 0.17% | 84 |
|
|
2025
Q1 | $362K | Buy |
4,989
+462
| +10% | +$33.5K | 0.19% | 75 |
|
|
2024
Q4 | $335K | Buy |
4,527
+57
| +1% | +$4.22K | 0.19% | 69 |
|
|
2024
Q3 | $295K | Buy |
4,470
+463
| +12% | +$30.6K | 0.17% | 76 |
|
|
2024
Q2 | $370K | Buy |
4,007
+185
| +5% | +$17.1K | 0.23% | 68 |
|
|
2024
Q1 | $365K | Buy |
3,822
+32
| +0.8% | +$3.06K | 0.25% | 62 |
|
|
2023
Q4 | $289K | Sell |
3,790
-42
| -1% | -$3.2K | 0.22% | 65 |
|
|
2023
Q3 | $265K | Buy |
3,832
+155
| +4% | +$10.7K | 0.21% | 67 |
|
|
2023
Q2 | $347K | Buy |
3,677
+181
| +5% | +$17.1K | 0.27% | 56 |
|
|
2023
Q1 | $289K | Sell |
3,496
-7
| -0.2% | -$579 | 0.26% | 59 |
|
|
2022
Q4 | $261K | Buy |
+3,503
| New | +$261K | 0.27% | 56 |
|